---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-111729"
form_type: "8-K"
ticker: "MRK"
cik: "0000310158"
company_name: "Merck & Co., Inc."
filed_at: "2022-10-27T23:59:59+00:00"
generated_at: "2026-06-23T00:19:15.456527+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Merck Q3 beats: rev $15B, non-GAAP EPS $1.85; raises FY outlook; Davis to become Chairman

## Summary
- Q3 revenue $15.0B (+14% YoY); GAAP EPS $1.28, non-GAAP EPS $1.85 (+4% from $1.78).
- KEYTRUDA sales $5.4B (+20%), GARDASIL sales $2.3B (+15%); LAGEVRIO contributed $436M.
- Raises FY2022 sales outlook to $58.5-59.0B (growth 20-21%); non-GAAP EPS guidance raised to $7.32-7.37.
- Executive Chairman Kenneth Frazier to retire Nov 30; CEO Robert Davis elected Chairman effective Dec 1.

## SEC filing metadata
- accession: 0001104659-22-111729
- form_type: 8-K
- ticker: MRK
- cik: 0000310158
- company_name: Merck & Co., Inc.
- filed_at: 2022-10-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310158/000110465922111729/0001104659-22-111729-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310158/000110465922111729/tm2227726d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-111729
- JSON: https://secwatch.observer/filing/0001104659-22-111729.json
- Plain text: https://secwatch.observer/filing/0001104659-22-111729.txt

## Key facts
- Earnings Releases
  Merck & Co., Inc. updated its the third quarter of 2022 guidance (raised).
  - Period: the third quarter of 2022
  - Guidance: raised
  - Result: reported results
  source text: Incorporated by reference is a press release issued by Merck & Co., Inc. (“Merck”) on October 27, 2022, regarding earnings for the third quarter of 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/310158/000110465922111729/0001104659-22-111729-index.htm
- Executive change
  Kenneth C. Frazier departed as Executive Chairman at Merck & Co., Inc..
  - Action: retire
  - Role: Executive Chairman
  source text: Kenneth C. Frazier, the Executive Chairman of Merck’s Board of Directors (the “Board”) will retire from the Board, effective November 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/310158/000110465922111729/0001104659-22-111729-index.htm
- Executive change
  Robert M. Davis was elected as Chairman of the Board at Merck & Co., Inc..
  - Action: elected
  - Role: Chairman of the Board
  source text: the Board unanimously elected Robert M. Davis, Merck’s current Chief Executive Officer and President as well as a Director on the Board to serve as Chairman of the Board, effective December 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/310158/000110465922111729/0001104659-22-111729-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.